Evaluation of the Role of Spirituality in Coping With and Surviving Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Little is known about the role a patient's spirituality plays in their quality of life. This
study consists of a series of questionnaires that ask questions about religion,
spirituality, and decisions about treatment.
All patients with newly diagnosed ovarian, primary peritoneal or fallopian tube cancer who
come to the Department of Gynecologic Oncology at M. D. Anderson and affiliated clinics for
care will be offered study participation.
Patients will be asked to complete a series of questionnaires at specific times: at the time
of diagnosis (before their second cycle of therapy begins), at the end of primary
chemotherapy, and one year later. The questionnaires should take a total of about 65 minutes
to complete, and patients can choose not to answer any question they do not want to answer.
Patients who agree to participate but do not have time to fill out the questionnaires during
their visits may return the questionnaire by mail in a pre-stamped envelope.
All participants will be asked to provide the following information: their age, religious
preference, race, marital status, date of diagnosis, stage of disease, and their current
treatment. This information will be on a data sheet and should take about 5 minutes to
complete.
Any collected information will be confidential. Each participant will be given a specific
identification number so that confidentiality can be maintained.
This study is partially funded by a research grant from the Blanton Davis Ovarian Cancer
Research Program, in Department of Gynecologic Oncology at M. D. Anderson.
This is an investigational study. About 115 participants will be enrolled in this
multicenter study. About 60 participants will be enrolled at M. D. Anderson.
Observational
Observational Model: Case-Only, Time Perspective: Prospective
Patient Response to Questionnaire (Spiritual assessments)
From diagnosis to completion of primary therapy and to 1 year after completion of primary therapy.
No
Lois M. Ramondetta, MD
Principal Investigator
M.D. Anderson Cancer Center
United States: Institutional Review Board
2004-0283
NCT00499512
August 2005
Name | Location |
---|---|
U.T.M.D. Anderson Cancer Center | Houston, Texas 77030 |
St. Luke's Episcopal Hospital | Houston, Texas 77030 |
Lyndon B. Johnson General Hospital | Houston, Texas 77026-1967 |
The Woman's Hospital of Texas | Houston, Texas 77054 |